Financials
- Market Capitalization 271.99 M
- Employee 35
- Founded 2008
- CEO N/A
- Website www.inhibikase.com
- Headquarter Delaware, United States
- FIGI BBG005TP2339
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-4.18
市销率
53.93
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 3389 | MGNX MacroGenics, Inc. - Common Stock | 4.30 USD | -4.44% | -9.47% | +8.59% | +173.89% | 273.32 M USD | ||
| 3398 | SABS SAB Biotherapeutics, Inc. - Common Stock | 3.60 USD | -3.49% | -7.69% | +4.65% | +48.76% | 275.27 M USD | ||
| 3410 | GLSI Greenwich LifeSciences, Inc. - Common stock | 19.03 USD | +2.48% | +2.48% | -22.07% | +78.02% | 279.33 M USD | ||
| 3433 | SRZN Surrozen, Inc. - Common Stock | 21.89 USD | -4.03% | -4.87% | -8.72% | +157.23% | 254.15 M USD |